Asembia 2021
Connect with One of Our Experts
- Tony Lanzone, Managing Director, Commercial Advisory Group, Syneos Health
- Adrian Garcia, SVP Managed Markets Strategy, Syneos Health
- Jon Haas, Sr Director, Market Access, Syneos Health
- Brian Siemak, VP Business Development, Market Access, Syneos Health
Featured Sessions:
Market Access Best Practice: Ensuring Success with Cross-Functional Teams
Market access success is no longer the responsibility of a single function within an organization. Cross-functional teams must come together from clinical development, commercial strategy, real world evidence, sales and marketing in order to properly define and communicate value to ensure access and reimbursement for today’s therapies. This panel – consisting of industry representatives from the C-suite, marketing and market access – will discuss best practices in value & access from Phase II through loss-of-exclusivity.
Date & Time: October 27, 1:00 PM-1:45 PM
Location: Bandol Meeting Room
Moderator:
Tony Lanzone
Managing Director, Commercial Advisory Group
Panelists:
Dave MacLeod
Head of Global Patient Services and Commercial Distribution at Amylyx Pharmaceuticals
Erin Mistry
SVP Payer Strategy, Government Affairs and Trade, Cormedix, Inc.
Robert Rouse
Head of US Market Access, CSL Behring
High-Touch, High-Impact and Highly Successful Strategies for Specialty-Lite Products
This session will focus on strategies for developing the right amount of support and services that provide optimal fulfillment rates for products that land somewhere between retail and specialty. Presenters will discuss integrating the most efficient mix of HUB services, field reimbursement, payer, sales and medical teams to prevent roadblocks for patients starting and staying on therapy.
Date & Time: October 28, 10:00 AM-10:45 AM
Location: Bandol 2 Meeting Room
Speaker:
Jon Haas
Sr. Director, Market Access Solutions, Syneos Health
